Over 350 Total Lots Up For Auction at Three Locations - MD 02/08, TX 02/10, Ontario 02/14

My report on ASTRO 2017

by Philip F. Jacobus, CEO | September 27, 2017
I was very impressed with ASTRO this year... Just like last year.

We all know that cancer treatment is multi-disciplinary by it's very nature and this show reflects that. Many specialties are represented at ASTRO and, as I have observed in previous years attending the event, there is a real spirit of cooperation in the air.

Defeating cancer is the common cause.

By my unofficial count the show was larger this year than last year.

Proton therapy was well represented at the show. That technology is now here to stay. Linear accelerators continue to dominate radiotherapy treatment and drug therapy remains a vital part of the tool kit.

There were lots on innovative technologies sprinkled throughout the show. Some new, and some I have seen before.

Varian introduced ASTRO attendees to Halcyon this year, the latest in its line of linac systems. It has a very unique look and I am told it is reasonably priced. Conceptually, it has some similarities to Accuray's Radixact, which also has a linac that rotates around the patient.

Elekta had the most interesting booth I have seen in a while.

Most of us know someone who has died of cancer. The companies and people at ASTRO are changing that.

View all The Jacobus Report Blog Posts

About Phil Jacobus

Phil Jacobus has been involved in health care since 1977, when he visited China to sell equipment. He has done business in 35 countries and still travels extensively. Phil is active in charity, helps rural clinics and always tries to help DOTmed users when he can.

Phil is a member of AHRA, HFMA, AAMI and the Cryogenic Society of America. He has contributed to a number of magazines and journals and has addressed trade groups.

Phil's proudest achievement is that he has been happily married to his wife Barbara since 1989, who helped him found DOTmed in 1998.



MRI-guided RT here and now. ASTRO update

September 29, 2017 08:19

While Elekta showed its Unity MR-Linac project for the first time, ViewRay showcased the MRIdian Linac, its second generation MRIGRT system. It has CE and FDA clearance. MRIdians are in clinical operation in leading institutions around the world. Seeing what to treat, on-table adaptive MR-guided therapy, is changing the paradigm in RT. 21 presentations by ViewRay users at ASTRO is quite impressive considering that no one else has a clinical system.

Log inor Register

to rate and post a comment

You Must Be Logged In To Post A Comment